Oakworth Capital’s Bruker BRKR Stock Holding History

Oakworth Capital’s Portfolio BRKR Stock Details BRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-120	Closed	-$8.87K	–	607
2023 Q2	$8.87K	Buy	+120	New	+$9.15K	﹤0.01%	480

Other funds holding BRKR

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PCA

Pallas Capital Advisors Braintree, Massachusetts $2.66B AUM 22.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Oakworth Capital's BRKR Position: Q3 2023 in Review

Oakworth Capital sold out of Bruker (BRKR) in Q3 2023, closing a stake of 120 shares — an estimated $8.87K sold.

Oakworth Capital first reported a position in BRKR in Q2 2023 and held it in 1 quarter. The position peaked at $8.87K in Q2 2023. 345 funds tracked by Wall St. Rank hold BRKR as of Q3 2023.

Oakworth Capital reported no remaining Bruker position as of Q3 2023 after selling out during the quarter.
Oakworth Capital sold 120 Bruker shares in Q3 2023, an estimated $8.87K.
Oakworth Capital first reported a position in Bruker in Q2 2023 and held it in 1 quarter.
Oakworth Capital's Bruker position peaked at $8.87K in Q2 2023.
345 funds tracked by Wall St. Rank held Bruker as of Q3 2023.

Based on Oakworth Capital's 13F filing for Q3 2023, filed 31 Oct 2023.